Balaxi Pharmaceuticals Ltd

Balaxi Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaxi Pharmaceuticals Ltd

₹ 120 -1.42%
04 Jul 3:58 p.m.
balaxiventures.in NSE: BALAXI
About

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]

Key Points

Product Portfolio
Balaxi Pharmaceuticals Limited has a rich portfolio of 610 pharmaceutical product registrations. The pharma product portfolio of the company includes Tablets (46%), Injectables(17%), Liquids (12%), Capsules (13%), and Others (12%). The pharma products are sourced from WHO-GMP certified contract manufacturers based in India, China, and Portugal. [1] [2] [3]

Website NSE
  • Market Cap ₹ 660 Cr.
  • Current Price ₹ 120
  • High / Low ₹ 151 / 80.0
  • Stock P/E 181
  • Book Value ₹ 22.3
  • Dividend Yield 0.00 %
  • ROCE 6.15 %
  • ROE 3.59 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -4.86%
  • Earnings include an other income of Rs.2.40 Cr.
  • Dividend payout has been low at 1.14% of profits over last 3 years
  • Company has high debtors of 399 days.
  • Working capital days have increased from 210 days to 326 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
22.60 29.18 33.51 17.95 20.65 26.45 28.26 23.07 30.35 25.04 16.55 12.70 15.90
18.01 24.21 28.25 14.82 16.75 22.21 24.73 19.50 24.94 21.27 15.64 12.42 15.70
Operating Profit 4.59 4.97 5.26 3.13 3.90 4.24 3.53 3.57 5.41 3.77 0.91 0.28 0.20
OPM % 20.31% 17.03% 15.70% 17.44% 18.89% 16.03% 12.49% 15.47% 17.83% 15.06% 5.50% 2.20% 1.26%
0.04 0.99 0.23 0.45 1.07 2.57 2.50 1.34 0.18 0.13 1.15 1.03 0.16
Interest 0.00 0.00 0.01 0.02 0.02 0.20 0.02 0.01 0.23 0.26 0.36 0.41 0.51
Depreciation 0.02 0.03 0.07 0.08 0.08 0.08 0.08 0.08 0.27 0.13 0.13 0.13 0.12
Profit before tax 4.61 5.93 5.41 3.48 4.87 6.53 5.93 4.82 5.09 3.51 1.57 0.77 -0.27
Tax % 31.45% 25.30% 25.51% 22.99% 27.72% 18.38% 32.88% 26.56% 22.59% 27.35% 24.84% 36.36% -114.81%
3.16 4.43 4.03 2.67 3.53 5.34 3.98 3.53 3.94 2.55 1.18 0.49 -0.58
EPS in Rs 0.63 0.89 0.81 0.53 0.71 1.07 0.80 0.70 0.77 0.50 0.23 0.10 -0.11
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.05 0.14 0.12 0.05 0.00 0.00 13.60 45.63 86.87 101.29 108.14 70.20
0.02 0.03 0.08 0.11 0.13 0.77 12.05 36.98 67.85 83.99 91.26 64.97
Operating Profit 0.03 0.11 0.04 -0.06 -0.13 -0.77 1.55 8.65 19.02 17.30 16.88 5.23
OPM % 60.00% 78.57% 33.33% -120.00% 11.40% 18.96% 21.89% 17.08% 15.61% 7.45%
0.03 0.05 0.12 0.00 0.00 0.00 0.89 0.59 1.81 2.75 6.60 2.40
Interest 0.00 0.01 0.01 0.05 0.04 0.00 0.00 0.05 0.15 0.10 0.51 1.54
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.09 0.25 0.52 0.51
Profit before tax 0.06 0.15 0.15 -0.11 -0.17 -0.77 2.44 9.18 20.59 19.70 22.45 5.58
Tax % 16.67% 26.67% 26.67% 36.36% 0.00% 0.00% 19.26% 29.30% 26.52% 25.53% 27.75% 34.59%
0.04 0.11 0.10 -0.08 -0.17 -0.77 1.97 6.50 15.13 14.67 16.22 3.65
EPS in Rs 0.31 0.07 -0.05 -0.11 -0.51 1.30 1.30 3.03 2.93 3.19 0.67
Dividend Payout % 175.00% 63.64% 91.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.41% 0.00% 0.00%
Compounded Sales Growth
10 Years: 86%
5 Years: 39%
3 Years: -7%
TTM: -35%
Compounded Profit Growth
10 Years: 42%
5 Years: 13%
3 Years: -38%
TTM: -78%
Stock Price CAGR
10 Years: %
5 Years: 56%
3 Years: 0%
1 Year: 16%
Return on Equity
10 Years: 20%
5 Years: 21%
3 Years: 16%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.70 0.70 3.04 3.04 3.04 3.04 3.04 10.00 10.00 10.00 10.18 10.90
Reserves 0.05 0.08 0.18 0.11 -0.72 -1.49 0.48 18.11 33.25 47.91 71.63 110.65
0.16 0.18 0.00 0.20 0.00 0.00 0.00 0.00 3.51 1.93 12.43 15.70
0.33 0.24 0.46 0.22 0.05 0.13 2.59 9.79 22.16 22.07 35.48 17.11
Total Liabilities 1.24 1.20 3.68 3.57 2.37 1.68 6.11 37.90 68.92 81.91 129.72 154.36
0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.19 0.69 2.20 7.89 7.09
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 2.83 2.31
Investments 0.47 0.19 3.42 3.29 0.00 0.00 0.00 0.10 19.54 19.61 19.54 19.88
0.77 1.01 0.26 0.28 2.37 1.67 6.10 37.61 48.69 59.53 99.46 125.08
Total Assets 1.24 1.20 3.68 3.57 2.37 1.68 6.11 37.90 68.92 81.91 129.72 154.36

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.32 -0.24 0.21 -0.03 -0.13 -0.68 -1.51 -14.37 13.46 8.89 -7.07 -1.83
-0.05 0.32 -3.11 0.13 2.67 -0.01 -0.01 -0.28 -20.03 -6.87 -2.29 0.46
-0.29 -0.07 2.38 -0.11 -0.24 0.00 0.00 18.10 3.49 -1.64 26.39 27.55
Net Cash Flow -0.02 0.01 -0.52 -0.02 2.30 -0.69 -1.51 3.44 -3.08 0.38 17.03 26.19

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 219.00 756.07 30.42 0.00 146.81 249.73 202.23 187.78 264.25 399.11
Inventory Days 9.23 0.12 0.00 6.62 5.43
Days Payable 81.27 95.96 76.73 80.38
Cash Conversion Cycle 219.00 756.07 30.42 0.00 146.81 177.69 106.38 187.78 194.14 324.16
Working Capital Days -1,825.00 573.57 -669.17 73.00 82.12 186.70 109.37 112.43 192.59 326.32
ROCE % 6.28% 17.11% 7.66% -1.83% -4.59% -39.79% 96.25% 58.36% 55.40% 37.15% 29.80%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Apr 2024
72.86% 72.86% 72.86% 72.86% 72.86% 72.69% 71.57% 71.22% 71.22% 71.22% 66.86% 66.36%
0.00% 0.00% 0.00% 0.00% 19.00% 18.95% 18.66% 18.57% 18.57% 18.57% 17.21% 17.08%
19.48% 19.48% 19.31% 19.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02%
7.65% 7.64% 7.83% 8.11% 8.11% 8.33% 9.75% 10.18% 10.18% 10.18% 15.91% 16.54%
No. of Shareholders 4,1423,8713,9884,1764,8004,7304,8595,1235,0475,0455,2065,132

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls